Search for: "MYLAN, INC." Results 201 - 220 of 674
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Aug 2004, 3:55 pm
West Virginia US District Judge Irene Keeley may rule as early as Monday on the legality of "authorized generics" in a dispute between the FDA and Mylan Laboratories, Inc.. [read post]
12 Apr 2017, 4:15 am by John M. Rogitz
Mylan, Inc. (2015-1113, 2015-1151, and 2015-1181) that imports certain subject matter from the specification into the claims... [read post]
23 Jul 2018, 2:38 pm by Jason Rantanen
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
3 Apr 2013, 4:45 am by Eric Guttag
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...]... [read post]
4 Jun 2012, 9:55 pm by Patent Docs
Mylan Pharmaceuticals, Inc. et al. 8:12-cv-01190; filed May 25, 2012 in the Middle District... [read post]
3 Mar 2012, 9:45 am by Lawrence B. Ebert
In an article titled Sector Snap: Generic competition and biotech drugs , one notes the irony that generic maker Teva is facing Hatch-Waxman challenges from Mylan Inc. and Novartis AG over its patented drug Copaxone, a drug for treatment of multiple sclerosis. [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE;… [read post]
24 Mar 2008, 5:09 am
We don't usually report on labor and employment cases in this space.Heck, we don't usually read labor and employment cases.But the recent decision in Mylan Pharmaceuticals , Inc. v. [read post]
18 Aug 2014, 6:48 am by Gregory B. Williams
Mylan Pharmaceuticals, Inc., et al., Civil Action No. 08-889-SLR (D.Del., August 14, 2014), the Court granted defendants’ motion for partial summary judgment of no willfulness with respect to their infringement of the patents-in-suit based upon defendants’ at risk launch of their generic versions of plaintiffs’ Amrix® products. [read post]
5 Dec 2017, 7:40 am by Sarah M Donnelly
Here are the amici curiae in the matter of Mylan Pharmaceuticals Inc. et al v. [read post]
5 Aug 2021, 7:38 pm by Patent Docs
The product is Semglee (insulin glargine-yfgn), produced by Mylan Pharmaceuticals, Inc., and under this approval, it is interchangeable with Lantus (insulin glargine) made by Sanofi. [read post]
14 May 2017, 9:55 pm by Patent Docs
Mylan Pharmaceuticals, Inc. v. [read post]